Fischeroside BCAS# 1307257-08-4 |
Quality Control & MSDS
Package In Stock
Number of papers citing our products
| Cas No. | 1307257-08-4 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C35H44O15 | M.Wt | 704.7 |
| Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Fischeroside B Dilution Calculator
Fischeroside B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.419 mL | 7.0952 mL | 14.1904 mL | 28.3809 mL | 35.4761 mL |
| 5 mM | 0.2838 mL | 1.419 mL | 2.8381 mL | 5.6762 mL | 7.0952 mL |
| 10 mM | 0.1419 mL | 0.7095 mL | 1.419 mL | 2.8381 mL | 3.5476 mL |
| 50 mM | 0.0284 mL | 0.1419 mL | 0.2838 mL | 0.5676 mL | 0.7095 mL |
| 100 mM | 0.0142 mL | 0.071 mL | 0.1419 mL | 0.2838 mL | 0.3548 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 6-Hydroxy-2-methoxyacetophenone 4-O-beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside
Catalog No.:BCX2116
CAS No.:2140317-59-3
- Biflorin
Catalog No.:BCX2115
CAS No.:89701-85-9
- 3alpha-Hinokiol
Catalog No.:BCX2114
CAS No.:107740-34-1
- Tellimagrandin I
Catalog No.:BCX2113
CAS No.:79786-08-6
- O-Methylglycosolone
Catalog No.:BCX2112
CAS No.:41303-25-7
- Garcinexanthone C
Catalog No.:BCX2111
CAS No.:1107620-69-8
- Mangostenone F
Catalog No.:BCX2110
CAS No.:1242438-70-5
- cis-N-Terrestriamide
Catalog No.:BCX2109
CAS No.:2170469-93-7
- Morindaparvin W
Catalog No.:BCX2108
CAS No.:2596365-67-0
- 25(27)-Ene-elephanoside H
Catalog No.:BCX2107
CAS No.:1592406-40-0
- Flindersine
Catalog No.:BCX2106
CAS No.:523-64-8
- Isorhamnetin 3-O-apiosyl (1->2)[rhamnosyl (1->6)]glucoside
Catalog No.:BCX2105
CAS No.:165605-18-5
- Isolophanthin B
Catalog No.:BCX2118
CAS No.:1370511-57-1
- 7-O-Methylhorminone
Catalog No.:BCX2119
CAS No.:122482-10-4
- Isocarthamidin 7-O-glucuronide
Catalog No.:BCX2120
CAS No.:119600-61-2
- 6,8-Di-C-beta-D-glucopyranosylacacetin
Catalog No.:BCX2121
CAS No.:28234-99-3
- 1,5-Epoxy-3S-hydroxy-1-(3,4-dihydroxy-5-methoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)heptane
Catalog No.:BCX2122
CAS No.:182369-54-6
- Callicapoic acid M1
Catalog No.:BCX2123
CAS No.:2756970-65-5
- 8-C-beta-D-(6-O-galloyl)glucosylnoreugenin
Catalog No.:BCX2124
CAS No.:152041-17-3
- 3'-Methoxynyasin
Catalog No.:BCX2125
CAS No.:1685246-20-1
- Isorhamnetin 3-sambubioside
Catalog No.:BCX2126
CAS No.:142059-76-5
- Ellagic acid glucoside
Catalog No.:BCX2127
CAS No.:163774-64-9
- Etuycomanol
Catalog No.:BCX2128
CAS No.:84633-28-3
- Plumbagic acid
Catalog No.:BCX2129
CAS No.:75640-06-1
Protective effect of Paeonia anomala extracts and constituents against tert-butylhydroperoxide-induced oxidative stress in HepG2 cells.[Pubmed:23349023]
Planta Med. 2013 Jan;79(2):116-22.
The fruit and root parts of Paeonia anomala L. are used for the treatment of many kinds of disorders in Mongolian traditional medicine. The protective effect of a fruit extract from P. anomala against tert-butylhydroperoxide-induced cell damage was evaluated in human hepatoma HepG2 cells and compared to that of a root extract from P. anomala on the basis of cell viability, generation of intracellular reactive oxygen species, cellular total glutathione concentration, and anti-genotoxicity. The fruit extract of P. anomala showed excellent protection against the oxidative stress when compared to the root extract, through free radical scavenging, enhancing cellular glutathione concentration, and inhibiting DNA damage. Chemical constituents in the fruit extract of P. anomala were investigated and two novel compounds, 2-hydroxy-6-methoxy-4-O-(6'-O-alpha-L-arabinofuranosyl-beta-D-glucopyranosyl)acetophenone (1) and 3,3'-di-O-methyl-4-O-(3''-O-galloyl-beta-D-glucopyranosyl)ellagic acid (2), along with 18 other known compounds were identified. Compound 2 showed better cytoprotection against tert-butylhydroperoxide than compound 1. Among other compounds isolated from the fruit extract, ellagic acid, methyl gallate, ethyl gallate, Fischeroside B, and quercetin derivatives showed potent protective effects against tert-butylhydroperoxide-induced oxidative stress via inhibiting reactive oxygen species generation and increasing total glutathione levels in HepG2 cells.
